Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapy testing.
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates).
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2016 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |